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Introduction
Acute pancreatitis is the third most common gastrointestinal
diagnosis leading to hospital admission in the United States
[1]. The spectrum of disease ranges from mild, self-limiting
edema of the pancreas to severe necrotizing pancreatitis,
which is life-threatening and requires thoughtful interventions.
Approximately 80% of cases of acute pancreatitis are mild and
the remainder will develop necrosis, with secondary infection
occurring in 30% of those patients [2–4].
Endoscopic therapy for walled-off pancreatic necrosis
(WOPN) was initially performed by Barron in 1996 and is widely
referred to as pancreatic necrosectomy [5]. Since the inception
of the endoscopic ultrasound (EUS)-guided transgastric ap-
proach, stent technology has advanced from plastic double-
pigtail stents to fully-covered metal stents and currently Lu-
men-apposing metal stents (LAMS) [6, 7]. LAMS facilitated the
popular “through-the-stent” technique. Use of LAMS facilitates
creation of a cyst-gastrostomy, allowing for same-session and
subsequent endoscopic necrosectomy [8].
Prior to the advent and development of endoscopic necro-
sectomy, surgical necrosectomy was the only option despite
being associated with significant morbidity. The surgical ap-
proach has also undergone an evolution to a video-assisted ret-
roperitoneal dissection, which continues to carry significant
morbidity, up to 6.8% in North America [9].
Endoscopic necrosectomy is less morbid than the surgical
approach for carefully selected patients, but is subject to com-
plications. It typically uses available endoscopic tools to at-
tempt to remove the infected necrosum; however, these tools
are not ideal and often lead to lengthy procedures.
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ABSTRACT
Background and study aim Endoscopic treatment of
walled-off pancreatic necrosis (WOPN) has been estab-
lished as an alternative to operative intervention for well se-
lected patients for many years.
Patients and methods A retrospective database of pa-
tients who underwent cap-assisted endoscopic necrosec-
tomy of symptomatic or infected WOPN using the assist-
ance of a sterilized banding cap was constructed. All proce-
dures were performed at a single center between January
2017 and June 2018.
Results Eight patients met the inclusion criteria for this
study. Contrast computed tomography scan was obtained
between the initial percutaneous or trans-gastric access
and initial necrosectomy. The WOPN had a median length
of 9.5 cm (range 3.2–14) and width of 5.3 cm (range 2.8–
11.6). Median duration of endoscopic debridement was 69
minutes (range 21–105). Four of six patients underwent a
second debridement with a median duration of 95 minutes
(range 16–108). No periprocedural adverse events occurr-
ed. Follow-up was at 6 months, and there were no addition-
al endoscopic or percutaneous interventions for recurrent
pancreatic fluid collections.
Conclusion The technique of cap-assisted necrosectomy
can allow for safe and efficient method of endoscopically
treating WOPN.
Case report
E912 Puri Nishant et al. Early experience with cap-assisted endoscopic pancreatic necrosectomy… Endoscopy International Open 2019; 07: E912–E915
Th
is
 d
oc
um
en
t w
as
 d
ow
nl
oa
de
d 
fo
r p
er
so
na
l u
se
 o
nl
y.
 U
na
ut
ho
riz
ed
 d
ist
rib
ut
io
n 
is 
st
ric
tly
 p
ro
hi
bi
te
d.
Despite the increase in incidence of acute pancreatitis and
demonstration of decreased hospital stays in patients who un-
derwent endoscopic rather than surgical necrosectomy, there
has not been any development of endoscopic tools to increase
the yield of endoscopic tissue requisition [10]. A novel tech-
nique of cap-assisted necrosectomy was recently described by
the author (N.P) and we now present this case series, detailing
our experience utilizing banding caps to assist with endoscopic
pancreatic necrosectomy [11].
Patients and methods
The IRB approved creation of a retrospective database of all pa-
tients that underwent cap-assisted necrosectomy for infected
or symptomatic WOPN. All cases since the report of the ap-
proach in 2017 were included [11]. Eight patients were identi-
fied who underwent endoscopic ultrasound (EUS)-guided
through-the stent endoscopic pancreatic necrosectomy. Base-
line demographic data (age, gender, body mass index [BMI])
were collected, as well as information on the etiology and pres-
ence of infection. Details about all endoscopic interventions,
including duration and utilization of LAMS, were collected.
Radiologic studies and interventions performed after diagnosis
of acute pancreatitis were reviewed to assess the treatment re-
sponse of the WOPN. The Charlson score, a prospectively-vali-
dated assessment of comorbidity, was calculated for each pa-
tient to illustrate pre-procedure health [12]. The procedures
were performed by two experienced endoscopists (N.P. and
W.S.) at a single institution. All endoscopic interventions hap-
pened a minimum of 4 weeks after onset of pancreatitis as is re-
commended by the American Society for Gastrointestinal
Endoscopy (ASGE) [7].
Technical methods
Details of the technique used for these cases were published in
a recent article [11]. EUS-guided cyst-gastrostomy was per-
formed with a cautery-enhanced lumen-apposing metal stent
(LAMS), 15mm×10mm (Axios, Boston Scientific, Natick, Mas-
sachusetts, United States). Interventional Radiology-guided
drains were placed in patients who did not have mature WOPN
while awaiting EUS-guided access. EUS-guided trans-gastric ac-
cess was performed prior to endoscopic debridement or in con-
junction with the first debridement.
The WOPN was entered through the LAMS, after an initial
debridement, a sterilized banding cap (6 shooter multiband li-
gator, Cook Medical, Bloomington, Indiana, United States) was
attached to the endoscope to apply suction from the stent lu-
men, which facilitated increased retrieval of necrotic material
(▶Fig. 1). While the cap was kept within the lumen of the stent,
a snare was opened, necrotic tissue was suctioned, and the
snare was used to either cut or pull away the necrotic debris.
Similarly, the raptor forceps were opened within the cap and
suction was applied. This facilitated safe and efficient removal
of large pieces of necrosum. Follow-up CT scans were done in
4 to 6 weeks to confirm resolution of the WOPN. If there was
resolution, the LAMS was endoscopically removed.
▶ Fig. 1 a, b Initial CT scan showing walled-off pancreatic necrosis (coronal and sagittal views). c Large tissue pieces removed with cap-
assisted snare. d Necrotic tissue removed by suction through a transparent banding cap. e endoscopic view of pancreas after necrosectomy.
f Post-cap-assisted necrosectomy CT scan demonstrating resolution of walled-off pancreatic necrosis.
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Results
Endoscopic pancreatic necrosectomy with cap assistance was
performed on eight patients during 2017 and 2018. Patient de-
tails and demographics are outlined in ▶Table 1. Median age
was 64.5 years (range 26–77). Contrast CT scan was obtained
between the initial percutaneous or trans-gastric access and
first endoscopic necrosectomy. The complex WOPN had a me-
dian length of 9.5 cm (range 3.2–17.8) and width of 5.8 cm
(range 2.8–11.6). Five of eight patients were being treated for
infected WOPN prior to their trans-gastric access. Median dura-
tion of endoscopic debridement was 69 minutes (range 21–
105). Six of eight patients underwent a second debridement
with a median duration of 61 minutes (range 16–108) (▶Table
2). No periprocedural adverse events (AEs) occurred. In four of
eight patients, the LAMS stent migrated out while pulling
large pieces of necrosum and required replacement in the
same cyst-gastrostomy tract using a non-cautery-enhanced
15mm×10mm LAMS. No recurrence of pancreatic fluid collec-
tion requiring endoscopic or percutaneous intervention occurr-
ed during the 6 months follow-up for seven of the eight pa-
tients. Patient 8 developed persistent necrosis resulting in an
enterovesicular fistula that required an additional percuta-
neous drainage followed by a video-assisted retroperitoneal
debridement. Patient five was the only patient with residual
fluid collection on post-procedure CT, however, no interven-
tions were performed. All cyst gastrostomy LAMS were re-
moved without AEs.
Discussion
One of the essential pitfalls of endoscopic necrosectomy is the
time-consuming nature of the procedure and the need for mul-
tiple endoscopic interventions. The median number of endo-
scopic sessions ranged from one to five in previously published
series. [5, 13–15] Precise reporting of the duration of individ-
ual procedures was provided in two large multicenter series by
Yasuda et al. and Gardner et al., who reported median proce-
dure times of 63 and 68 minutes, respectively (range 25–179)
[15, 16].
The technical advantages of cap-assisted necrosectomy re-
sulted in clinical and radiographical resolution for 75% of pa-
tients. We believe that the reason why this technique provides
a significant component of safety to the procedure is because
application of suction to the WOPN from within the LAMS only
suctions necrotic material and not viable tissue into the cap,
thereby only removing the necrosum. In addition, the cap pro-
tects the lattice of the stent from endoscopic instruments,
which decreases the likelihood of dislodging the stent during
the necrosectomy. Use of the banding cap had enough length
to accommodate an adequate amount of tissue, which enabled
the snare or the forceps to grab a large portion of the necro-
sum. However, the currently used banding cap does have a
▶ Table 1 Patient and pancreatitis characteristics
Pa-
tient
Age
(Years)
BMI,
kg/m2
Gen-
der
Etiology
of pan-
creatitis
Carlson
comor-
bidity
index
Presence
of chron-
ic pan-
creatitis
Interval be-
tween acute
pancreatitis
and first en-
doscopic in-
tervention
(Months)
CT scan meas-
urement of
WOPN prior
to endoscopic
necrosectomy
(length×width
[cm])
WOPN status at
follow up CT scan
(days since final
necrosectomy)
1 77 23 M Gallstone/
post pro-
cedure
5 No 13 9.5 ×5.0 Resolved, 22 days
2 65 27 M Idiopathic 4 No 4 9.5 ×5.6 Decreased, 15 days
later
Resolved, 110 days
3 26 40 F Gallstone/
post pro-
cedure
0 No 8 3.2 ×2.9 Decreased, 37 days
Resolved, 66 days
4 73 25 M Alcohol
induced
3 No 2 12.3 ×11.6 Resolved, 34 days
5 41 32 M Alcohol
induced
3 Yes 4 9×2.8 Decreased, 46 days
Resolved, 52 days
6 75 37 F Idiopathic 6 Yes 2 14×8 Resolved, 29 days
7 28 26 M Alcohol
induced
0 Yes 15 9.5 ×6 Decreased, 34 days
8 64 25 M Gallstone 3 No 3 17.8 ×10 No resolution
Resolved after VARD
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ledge on the flare, and it is unclear whether this ledge catches
onto the stent to displace it or if it is the larger piece of necro-
sum that pushes the stent out.
The authors understand that banding caps are approved for
single use only, but due to lack of necrosectomy tools, the caps
were used after adequate sterilization. Major limitations of this
descriptive study beyond those inherent in retrospective inves-
tigations is the low sample size and variation in the timing of
the post-procedure imaging.
Conclusion
This novel technique of cap-assisted necrosectomy gives
endoscopists a new tool for performing pancreatic necrosec-
tomies. Future prospective studies are needed to establish the
clinical and economical benefit of cap-assisted pancreatic ne-
crosectomy.
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▶ Table 2 Details of percutaneous and endoscopic therapy
Pa-
tient
Transgastric or
transabdominal
drainage prior
to necrosectomy
Necrosec-
tomy at
first drain-
age proce-
dure (yes,
no)
Duration
of endo-
scopic
proce-
dure 1
(minutes)
Interval
between
debride-
ment 1
and 2
(days)
Duration
of endo-
scopic
proce-
dure 2
(minutes)
Interval
between
debride-
ment 2
and 3
(days)
Duration
of endo-
scopic
proce-
dure 3
(minutes)
Interval
between
debride-
ment 3
and 4
(days)
Duration
of endo-
scopic
proce-
dure 4
(minutes)
1 Transabdominal Yes 71 3 104
2 Transgastric No 105 4 20
3 Transgastric No 81
4 Transgastric No 66 23 108
5 Transgastric No 21
6 Transgastric No 41 6 86
7 Transgastric No 10 2 21 7 59
8 Transgastric Yes 66 3 36 4 66 16 36
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